Zealand Pharma Investor Relations Material
Latest events
Q1 2025
Zealand Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Zealand Pharma
Access all reports
Zealand Pharma, a biotechnology company, engages in discovery, development, and commercialization of peptide therapeutics for metabolic diseases, gastrointestinal diseases and diseases of the central nervous system in Denmark.
Key slides for Zealand Pharma
Q1 2025
Zealand Pharma
Q1 2025
Zealand Pharma
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ZEAL
Country
🇩🇰 Denmark